Substance / Medication

Paromomycin

Overview

Active Ingredient
paromomycin
RxNorm CUI
7934

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials.
Kim Dae Hyun, Chung Hye Jin, Bleys Joachim et al. · PLoS Negl Trop Dis · 2009
PMID: 19221595Meta-AnalysisFull text (PMC)
Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis.
Verrest Luka, Roseboom Ignace C, Wasunna Monique et al. · J Antimicrob Chemother · 2023
PMID: 37726401RCTFull text (PMC)
Pharmacokinetics and absorption of paromomycin and gentamicin from topical creams used to treat cutaneous leishmaniasis.
Ravis William R, Llanos-Cuentas Alejandro, Sosa Nestor et al. · Antimicrob Agents Chemother · 2013
PMID: 23877689RCTFull text (PMC)
Effect of in-feed paromomycin supplementation on antimicrobial resistance of enteric bacteria in turkeys.
Kempf Isabelle, Le Roux Aurélie, Perrin-Guyomard Agnès et al. · Vet J · 2013
PMID: 23800604RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Paromomycin (substance)
SNOMED CT
38044001
UMLS CUI
C0030576
RxNorm CUI
7934

Clinical Data

This intervention maps to 7 entities in the Healos knowledge graph.

7
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.